Search results for: hospital

Celecoxib & Cardiovascular Death: NSAID Safety Under Review

Michele B. Kaufman, PharmD, BCGP | December 7, 2016

A recent study showed that at moderate doses celecoxib may be noninferior with respect to cardiovascular safety compared with ibuprofen or naproxen…

Ultrasound for Underserved Patients

Karen Appold | December 2, 2016

Beverly Johnson, MD, has experienced exactly how rheumatologists and their patients benefit from musculoskeletal ultrasound imaging for the diagnosis and treatment of autoimmune disease…

New ARHP President Shares Her Story

Carol Patton | November 30, 2016

Back in 1999, Afton Hassett, PsyD, attended her first ACR/ARHP Annual Meeting, after receiving the suggestion from Leonard Sigal, MD, a professor of medicine in the Division of Rheumatology at Rutgers University’s Robert Wood Johnson Medical School (RWJMS). Since 2003, Dr. Sigal has served as a volunteer Clinical Professor at the school. At the time, Dr….

A Glimpse into the Life of New ACR President, Dr. Sharad Lakhanpal

Carol Patton | November 30, 2016

Born and raised in Lucknow, India, Sharad Lakhanpal, MBBS, MD, vividly remembers his father’s stories of traveling to the U.S. As a young boy, he grew intrigued, imagined living here and knew that someday he would narrate his own adventures about this country. As president of the ACR and a practicing rheumatologist at Rheumatology Associates…

FDA Update on Rituximab & Etanercept; Plus New ACP Gout Guideline

Michele B. Kaufman, PharmD, BCGP | November 30, 2016

The FDA is considering an application for subcutaneous rituximab and has approved an application for etanercept to treat pediatric patients with plaque psoriasis…

Shingles Vaccination Not at Goal Levels for U.S. Seniors

Madeline Kennedy | November 28, 2016

(Reuters Health)—Just one in five people over age 60 in the U.S. have been vaccinated against a painful eruption of herpes zoster (shingles), despite recommendations that all of them should get the shot. It’s estimated that among people over age 50, one in three will eventually develop shingles. After age 80, half of adults have…

Rheumatologists Reflect: What Drew Them to the Profession & How They Can Attract Others

Karen Appold | November 25, 2016

Each rheumatologist’s path to the specialty is unique. Here, three practicing rheumatologists share what inspired them to become rheumatologists, what brings them fulfillment and how to bring others into the specialty…

Reinitiating TNF Blockers after Tuberculosis Treatment

Michele B. Kaufman, PharmD, BCGP | November 23, 2016

A retrospective study showed that patients who have rheumatic disease and develop tuberculosis may be able to resume anti-TNF therapy and other biologic agents…

Patients with Parkinson’s Disease Are at Risk for Carpal Tunnel Syndrome

Lara C. Pullen, PhD | November 21, 2016

Patients with Parkinson’s disease may be at risk of carpal tunnel syndrome (CTS). New research examined why patients with Parkinson’s have a higher incidence of CTS than that of the general population. The study found that those patients who underwent subthalamic nucleus deep brain stimulation to monitor them for neuropathy may develop CTS…

Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

Kimberly Retzlaff | November 16, 2016

The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…